# Sutro Biopharma, Inc.: Form 8-K, filed Sep 4, 2020

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2020-09-04
- Accepted by EDGAR: Sep 3, 2020, 19:00 ET
- Period: 2020-09-03
- Accession: 0001564590-20-042563
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/stro-8k_20200903.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/stro-8k_20200903.htm

Filed Sep 4, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-042563. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.